Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $2.7M | ﹤0.01% |
47,100
+20,600
| +78% | +$1.21M |
|
1852
NewMarket
NEU
$8.85B
| $2.69M | ﹤0.01% |
5,100
-1,682
| -25% | -$901K |
|
1853
State Street SPDR S&P Insurance ETF
KIE
$684M
| $2.69M | ﹤0.01% |
47,600
-5,700
| -11% | -$332K |
|
1854
Alphatec Holdings
ATEC
$1.51B
| $2.68M | ﹤0.01% |
292,100
+150,500
| +106% | +$1.2M |
|
1855
Liquidia Corp
LQDA
$6.66B
| $2.68M | ﹤0.01% |
+228,000
| New | +$2.49M |
|
1856
Tucows
TCX
$126M
| $2.67M | ﹤0.01% |
155,851
-9,300
| -6% | -$165K |
|
|
SEG
1857
Seaport Entertainment Group
SEG
$355M
| $2.67M | ﹤0.01% |
+95,421
| New | +$2.75M |
|
|
LAND
1858
Gladstone Land Corp
LAND
$358M
| $2.66M | ﹤0.01% |
245,600
+114,600
| +87% | +$1.42M |
|
1859
Liberty Latin America Class A
LILA
$1.69B
| $2.66M | ﹤0.01% |
616,326
+8,096
| +1% | +$44.4K |
|
|
SCS
1860
DELISTED
Steelcase
SCS
| $2.66M | ﹤0.01% |
224,700
+19,000
| +9% | +$244K |
|
1861
Esquire Financial Holdings
ESQ
$1.55B
| $2.66M | ﹤0.01% |
33,400
-22,400
| -40% | -$1.61M |
|
1862
Byrna Technologies
BYRN
$95.5M
| $2.65M | ﹤0.01% |
92,100
-47,600
| -34% | -$933K |
|
1863
iShares ESG Aware MSCI EM ETF
ESGE
$6.84B
| $2.65M | ﹤0.01% |
79,300
+68,100
| +608% | +$2.4M |
|
1864
Grindr
GRND
$2.78B
| $2.64M | ﹤0.01% |
148,165
-196,235
| -57% | -$2.86M |
|
1865
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $2.64M | ﹤0.01% |
10,400
+6,000
| +136% | +$1.54M |
|
1866
RCI Hospitality Holdings
RICK
$236M
| $2.64M | ﹤0.01% |
45,900
+922
| +2% | +$45K |
|
1867
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $2.63M | ﹤0.01% |
108,900
-307,786
| -74% | -$7.52M |
|
1868
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.75B
| $2.63M | ﹤0.01% |
42,456
-12,444
| -23% | -$775K |
|
1869
Kontoor Brands
KTB
$4.69B
| $2.62M | ﹤0.01% |
30,700
+24,500
| +395% | +$2.1M |
|
1870
Beazer Homes USA
BZH
$872M
| $2.62M | ﹤0.01% |
+95,328
| New | +$3.04M |
|
1871
Equity Bancshares
EQBK
$1.06B
| $2.61M | ﹤0.01% |
61,600
-4,800
| -7% | -$213K |
|
1872
Schwab 1000 Index ETF
SCHK
$5.96B
| $2.61M | ﹤0.01% |
92,200
+46,000
| +100% | +$1.31M |
|
|
ASRT
1873
DELISTED
Assertio
ASRT
| $2.61M | ﹤0.01% |
199,566
-16,029
| -7% | -$239K |
|
1874
Valens Semiconductor
VLN
$210M
| $2.61M | ﹤0.01% |
1,001,930
+293,230
| +41% | +$587K |
|
|
PSTX
1875
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.6M | ﹤0.01% |
271,200
-626,403
| -70% | -$3.27M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.